Dietitians are tearing their hair out over these cases, because physicians should absolutely know better
in Nutrients compiled clinical and experimental evidence demonstrating that hydroxytyrosol improves lipid profiles, glycaemia, and insulin sensitivity while counteracting oxidative and inflammatory processes (Peyrol et al., 2017)
The Phase II RESCUE trial subsequently evaluated targeting the more downstream IL-6 with ziltivekimab in participants with CKD and elevated high-sensitivity CRP (hsCRP) [83]
However, most human trials examining NAD+ precursors for weight reduction show minimal fat loss compared to placebo, and no major clinical guidelines recommend NAD+ as a primary weight management intervention
The Medicare GLP-1 Bridge program launching in July 2026 will provide access to Wegovy, Zepbound, and Foundayo at just $50 per month for eligible beneficiaries through the end of 2027, with the BALANCE Model providing a long-term path for continued Part D coverage beyond that